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Background: The association of rs3757354 single nucleotide polymorphism (SNP) in the E3 ubiquitin ligase myosin
regulatory light chain-interacting protein (MYLIP, also known as IDOL) gene and serum lipid levels is not well
known in the general population. The present study aimed to detect the association of rs3757354 SNP and several
environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Method: A total of 627 subjects of Bai Ku Yao minority and 614 participants of Han nationality were randomly
selected from our stratified randomized cluster samples. Genotyping of the rs3757354 SNP was performed by
polymerase chain reaction and restriction fragment length polymorphism combined with gel electrophoresis, and
then confirmed by direct sequencing.
Results: The levels of serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density
lipoprotein cholesterol (LDL-C), apolipoprotein (Apo) AI and ApoB were lower in Bai Ku Yao than in Han (P < 0.05-
0.001). The frequency of G allele was 49.92% in Bai Ku Yao and 56.27% in Han (P < 0.05). The frequencies of AA, GA
and GG genotypes were 25.52%, 49.12% and 25.36% in Bai Ku Yao, and 19.87%, 47.72% and 32.41% in Han (P <
0.05); respectively. There were no significant differences in the genotypic and allelic frequencies between males and
females in both ethnic groups. The levels of HDL-C in Bai Ku Yao were different among the genotypes (P < 0.05),
the G allele carriers had higher serum HDL-C levels than the G allele noncarriers. The levels TC, HDL-C and ApoAI in
Han were different among the genotypes (P < 0.05 for all), the participants with GA genotype had lower serum TC,
HDL-C and ApoAI levels than the participants with AA genotype. These findings were found only in females but
not in males. The levels of TG and HDL-C in Bai Ku Yao were correlated with the genotypes, whereas the levels of
TC in Han, and TC, LDL-C in Han females were associated with the genotypes (P < 0.05 for all). Serum lipid
parameters were also correlated with age, sex, alcohol consumption, cigarette smoking, blood pressure, and body
mass index in both ethnic groups (P < 0.05-0.001).
Conclusions: The present study suggests that the MYLIP rs3757354 SNP is associated with serum TC, HDL-C and
ApoAI levels in the Bai Ku Yao and Han populations. But the association is different between the two ethnic groups.* Correspondence: yinruixing@yahoo.com.cn
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Many epidemiological and clinical studies have shown
that dyslipidemia is strongly associated with an increased
risk of coronary artery disease (CAD) [1-5]. It is gener-
ally agreed that dyslipidemia is a complex trait caused by
genetic factors and multiple environmental risk factors
such as diet, alcohol consumption, cigarette smoking,
obesity, physical inactivity, hypertension and their inter-
actions [6-9]. Family studies have shown that in many
populations, genetic polymorphisms could account for
half of the variation in serum lipid phenotypes [10,11],
and it is clear that serum lipid levels are strongly influ-
enced by the genetic constitution of each individual.
Recent genome-wide association studies (GWAS) in
different populations have identified more than 95 loci
influence plasma lipid levels [12-23]. These studies eval-
uated large samples of normolipidemic individuals and
showed that several new single nucleotide polymorph-
isms (SNPs) had replicable modest associations with
plasma concentrations of total cholesterol (TC), triglycer-
ide (TG), low-density lipoprotein cholesterol (LDL-C),
and high-density lipoprotein cholesterol (HDL-C) [15-
18]. In addition, GWAS also discovered a number of
novel loci that influence serum lipid phenotypes [23-25].
One of these newly identified SNPs is the E3 ubiquitin
ligase myosin regulatory light chain-interacting protein
(MYLIP, also known as IDOL) gene. MYLIP locates on
chromosome 6p22.3 which stimulates ubiquitination of
the low-density lipoprotein receptor (LDLR) on its cyto-
plasmic tail, thereby directing its degradation [24]. It is
also known as post-transcriptional regulator of LDLR
abundance [26-33]. The LXR-MYLIP-LDLR pathway pro-
vides a complementary pathway to sterol regulatory
element-binding proteins for the feedback inhibition of
cholesterol uptake [34]. Several SNPs including MYLIP
rs9370867, rs3757354 and rs2327951 have been asso-
ciated with human plasma cholesterol [35]. However, the
rs3757354 SNP has not been reported in prior GWAS
for plasma lipid concentration [24]. Teslovich et al. [23]
demonstrated 95 loci that showed genome-wide signifi-
cant association with blood lipid, and rs3757354 was
shown significant association with LDL-C and TC.
Weissglas-Volkov et al. [35] demonstrated that N342S in
MYLIP was associated with higher TC levels in Mexican
dyslipidemic individuals. However, Santos et al. [36]
involved MYLIP p.N342S polymorphism is not asso-
ciated with lipid profiles in the Brazilian population and
indicated that further studies are needed to reaffirm the
MYLIP polymorphism function. Besides, Banka et al.
[37] and Kararigas et al. [38] reported that MYLIP is a
sex-specific element influencing contractile function.
Thus, it would be interesting to characterize the full im-
pact of the relationship between rs3757354 and serum
lipid levels.China is a multiethnic country. There are 56 ethnic
groups. Han nationality is the largest ethnic group, and
Yao nationality is the eleventh largest minority among
the 55 minority groups according to the population size.
Bai Ku Yao (White-trouser Yao), an isolated subgroup of
Yao nationality, is named so because all the men wear
white knee-length knickerbockers. The population size is
about 30000. Because of isolation from the other ethnic
groups, the special customs and cultures including their
clothing, intra-ethnic marriages, ballad, funeral, bronze
drum, spinning top, dietary habits, and corn wine and
rum intakes are still completely preserved to the present
day. In several previous studies, we found that the serum
lipid concentrations were lower in Bai Ku Yao than in
Han from the same region [7,8,39]. This ethnic differ-
ence in serum lipid profiles is still unknown. We
hypothesized that there may be significant differences in
some genetic polymorphisms between the two ethnic
groups [40-44]. Therefore, the aim of the present study
was to detect the association between rs3757354 SNP in
the MYLIP gene and several environmental factors with




The participants in the present study included 627 indi-
viduals of Bai Ku Yao who live in Lihu and Baxu villages
in Nandan County, Guangxi Zhuang Autonomous Re-
gion, People’s Republic of China. They were randomly
selected from our previous stratified randomized cluster
samples [7]. The ages of the participants ranged from 17
to 80 years, with an average age of 40.59 ± 14.21 years.
There were 303 males (48.3%) and 324 females (51.7%).
All participants were rural agricultural workers. During
the same period, a total of 614 people of Han nationality
who reside in the same villages were also randomly
selected from our previous stratified randomized cluster
samples. The mean age of the subjects was 40.94 ± 15.56
years (range 15 to 86). There were 294 men (47.9%) and
320 women (52.1%). All of them were also rural agricul-
tural workers. All study subjects were essentially healthy
and had no evidence of any chronic illness, including
hepatic, renal, or thyroid. The participants with a history
of heart attack or myocardial infarction, stroke, congest-
ive heart failure, diabetes or fasting blood glucose ≥ 7.0
mmol/L determined by glucose meter were excluded
from the analyses. The participants were not taking
medications known to affect serum lipid levels (lipid-
lowering drugs such as statins or fibrates, beta-blockers,
diuretics, or hormones). The experimental design was
approved by the Ethics Committee of the First Affiliated
Hospital, Guangxi Medical University. All participants in
this study had provided written informed consent.
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The survey was carried out using internationally stan-
dardized methods, following a common protocol [45].
All participants underwent a complete history, physical
examination, and laboratory assessment of cardiovascu-
lar risk factors, including lifestyle factors, family history
of myocardial infarction, hypertension and diabetes mel-
litus. Information on demographics, socioeconomic sta-
tus, and lifestyle factors was collected with standardized
questionnaires. The alcohol information included ques-
tions about the number of liangs (about 50 g) of rice
wine, corn wine, rum, beer, or liquor consumed during
the preceding 12 months. Alcohol consumption was
categorized into groups of grams of alcohol per day:
< 25 and ≥ 25. Smoking status was categorized into
groups of cigarettes per day: < 20 and ≥ 20. At the phys-
ical examination, several parameters, such as height,
weight, and waist circumference were measured. Sitting
blood pressure was measured three times with the use of
a mercury sphygmomanometer after the subjects had a
5-minute rest, and the average of the three measure-
ments was used for the level of blood pressure. Systolic
blood pressure was determined by the first Korotkoff
sound, and diastolic blood pressure by the fifth Korotk-
off sound. Body weight, to the nearest 50 grams, was
measured using a portable balance scale. Subjects
were weighed without shoes and in a minimum of
clothing. Height was measured, to the nearest 0.5 cm,
using a portable steel measuring device. From these
two measurements body mass index (BMI, kg/m2) was
calculated.
Determination of serum lipid levels
Venous blood samples (5 mL) were collected from all
subjects after an overnight (at least 12 hours) fast. A part
of the sample (2 mL) was collected into glass tubes and
allowed to clot at room temperature, and used to deter-
mine serum lipid levels. Another part of the sample (3
mL) was transferred to tubes with anticoagulate solution
(4.80 g/L citric acid, 14.70 g/L glucose, and 13.20 g/L
tri-sodium citrate) and used to extract DNA. The levels
of TC, TG, HDL-C, and LDL-C in the samples were
measured according to standard enzymatic methods.
Serum apolipoprotein (Apo) AI and ApoB levels were
detected by the immunoturbidimetric immunoassay. All
determinations were performed with an autoanalyzer
(Type 7170A; Hitachi Ltd., Tokyo, Japan) in the Clinical
Science Experiment Center of the First Affiliated Hos-
pital, Guangxi Medical University.
DNA preparation and genotyping
Genomic DNA was isolated from peripheral blood leu-
kocytes using the phenol-chloroform method [40-44].
The extracted DNA was stored at −80°C until analysis.Genotyping of the rs3757354 SNP was performed by
polymerase chain reaction and restriction fragment
length polymorphism (PCR-RFLP). PCR amplification
was performed using 5'-ACAGAGCAAAAGACCCTGT
CTC-3' and 5'-AAAGAACTGTGTGTGGGAGGAT-3'
(Sangon, Shanghai, People’s Republic of China) as the
forward and reverse primer pairs; respectively. Each
amplification reaction system of a total volume of 25 μL,
comprised 100 ng (2 μL) of genomic DNA; 1.0 μL of
each primer (10 μmo1/L); 12.5 μL 2 × Taq PCR Master-
Mix (constituent: 0.1 U Taq polymerase/μL, 500 μM
dNTP each, 20 mM Tris–HCl, pH 8.3, 100 mM KCl, 3
mM MgCl2, and stabilizers), and nuclease-free water 8.5
μL. After initial denaturizing at 95°C for 5 min, the reac-
tion mixture was subjected to 30 cycles of denaturation
at 95°C for 30 s, annealing at 61°C for 45 s and exten-
sion 1 min at 72°C, followed by a final 5 min extension
at 72°C. After electrophoresis on a 1.5% agarose gel with
0.5 μg/mL ethidium bromide, the amplification products
were visualized under ultraviolet light. Then 10.0 U of
HaeIII restriction enzyme, 8 μL nuclease-free water and
1 μL of 10 × buffer solution were added directly to the
PCR products (5 μL) and digested at 37°C overnight.
After restriction enzyme digestion of the amplified
DNA, genotypes were identified by electrophoresis on
2.0% agarose gel and visualized with ethidium-bromide
staining ultraviolet illumination. Genotypes were scored
by an experienced reader blinded to epidemiological
data and serum lipid levels.DNA sequencing
Six samples (AA, GA and GG genotypes in two; respect-
ively) detected by the PCR-RFLP were also confirmed by
direct sequencing. The PCR products were purified by
low melting point gel electrophoresis and phenol extrac-
tion, and then the DNA sequences were analyzed in
Shanghai Sangon Biological Engineering Technology &
Services Co., Ltd., People’s Republic of China.Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI, ApoB levels and the ratio of ApoAI to ApoB in
our Clinical Science Experiment Center were 3.10–5.17,
0.56–1.70, 1.16–1.42, 2.70–3.20 mmol/L, 1.00–1.78,
0.63–1.14 g/L, and 1.00–2.50; respectively [40]. The
individuals with TC > 5.17 mmol/L and/or TG > 1.70
mmol/L were defined as hyperlipidemic [7,8]. Hyperten-
sion was diagnosed according to the criteria of 1999
World Health Organization-International Society of
Hypertension Guidelines for the management of hyper-
tension [46,47]. The diagnostic criteria of overweight
and obesity were according to the Cooperative Meta-
analysis Group of China Obesity Task Force. Normal
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< 24, 24–28, and > 28 kg/m2; respectively [48].
Statistical analysis
Epidemiological data were recorded on a pre-designed
form and managed with Excel software. The statistical
analyses were done with the statistical software package
SPSS 13.0 (SPSS Inc., Chicago, Illinois). Quantitative
variables were expressed as mean ± standard deviation
(serum TG levels were presented as medians and inter-
quartile ranges). Qualitative variables were expressed as
percentages. Allele frequency was determined via direct
counting, and the standard goodness-of-fit test was used
to test the Hardy-Weinberg equilibrium. Difference in
genotype distribution between the groups was obtained
using the chi-square test. The difference in general char-
acteristics between two ethnic groups was tested by the
Student’s unpaired t-test. The association of genotypes
and serum lipid parameters was tested by analysis of co-
variance (ANCOVA). Age, sex, BMI, blood pressure, al-
cohol consumption, and cigarette smoking were
included in the statistical models as covariates. MultipleTable 1 The general characteristics and serum lipid levels in t






Body mass index (kg/m2) 22.28±2.39
Systolic blood pressure (mmHg) 119.69±17.23
Diastolic blood pressure (mmHg) 75.94±9.58
Pulse pressure (mmHg) 43.75±12.86
Cigarette smoking [n (%)]
Nonsmoker 415 (66.19)
< 20 cigarettes/day 92 (14.67)
≥20 cigarettes/day 120 (19.14)
Alcohol consumption [n (%)]
Nondrinker 331 (52.19)
< 25 g/day 189 (30.14)
≥25 g/day 107 (17.07)
Total cholesterol (mmol/L) 4.38±0.93
Triglyceride (mmol/L) 0.99 (0.66)
HDL-C (mmol/L) 1.70±0.42
LDL-C (mmol/L) 2.57±0.78
Apolipoprotein (Apo) AI (g/L) 1.33±0.32
ApoB (g/L) 0.84±0.23
ApoAI/ApoB 1.72±0.80
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholester
difference between the two ethnic groups was determined by the Wilcoxon-Mann–linear regression analyses adjusted for age, sex, BMI,
blood pressure, alcohol consumption, and cigarette
smoking were also performed to assess the association
of serum lipid levels with genotypes (AA = 1, GA = 2,
GG = 3) and several environment factors. A P value of
less than 0.05 was considered statistically significant.Results
General characteristics and serum lipid levels
The general characteristics and serum lipid levels be-
tween the Bai Ku Yao and Han populations are pre-
sented in Table 1. The levels of height, weight, systolic
blood pressure, pulse pressure, serum TC, HDL-C, LDL-
C, ApoAI,and ApoB were lower in Bai Ku Yao than in
Han (P < 0.05-0.001), whereas the percentage of subjects
who smoked cigarettes or consumed alcohol was higher
in Bai Ku Yao than in Han (P < 0.001). There were no
significant differences in the levels of BMI, diastolic
blood pressure, serum TG, the ratio of ApoAI to ApoB
and the ratio of male to female between the two ethnic
groups (P > 0.05 for all).he Bai Ku Yao and Han populations












78 (12.70) 17.463 0.000
417 (67.91)
121 (19.71)
76 (12.38) 29.922 0.000
4.77±0.99 −7.123 0.000






ol. The value of triglyceride was presented as median (interquartile range), the
Whitney test.
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After the genomic DNA of the samples was amplified by
PCR and imaged by 1.5% agarose gel electrophoresis, the
PCR products of 387 bp nucleotide sequences could be
seen in the samples (Figure 1). The genotypes identified
were named according to the presence or absence of the
enzyme restriction sites. The presence of the cutting site
indicates the G allele, while its absence indicates the A
allele (cannot be cut). Thus, AA genotype is homozygote
for the absence of the site (bands at 387 bp), GA geno-
type is heterozygote for the absence and presence of the
site (bands at 387-, 306- and 81-bp), and GG genotype is
homozygote for the presence of the site (bands at 306-
and 81- bp; Figure 2).Figure 2 Genotyping of rs3757354 SNP in the MYLIP gene. Lane
M, 100 bp marker ladder; lanes 1 and 2, AA genotype (387 bp); lanes
3 and 4, GA genotype (387-, 306- and 81-bp); and lanes 5 and 6, GG
genotype (306- and 81-bp).Nucleotide sequences
The results were shown as AA, GA and GG genotypes
of the rs3757354 SNP by PCR-RFLP, the genotypes were
also confirmed by sequencing (Figure 3); respectively.Genotypic and allelic frequencies
The genotypic and allelic frequencies of rs3757354 SNP
in the both ethnic groups are shown in Table 2. The
genotype distribution followed the Hardy-Weinberg
equilibrium. The A and G allele frequencies were 50.08%
and 49.92% in Bai Ku Yao, and 43.73% and 56.27% in
Han (P < 0.05); respectively. The frequencies of AA, GA
and GG genotypes were 25.52%, 49.12% and 25.36% in
Bai Ku Yao, and 19.87%, 47.72% and 32.41% in Han (P <
0.05); respectively. There were no significant differences
in the genotypic and allelic frequencies between males
and females in both ethnic groups.Figure 1 Electrophoresis of PCR products of the samples. Lane
M, 100 bp marker ladder; lanes 1–5, samples. The 387 bp bands are
the target genes.Genotypes and serum lipid levels
As shown in Table 3, the levels of HDL-C in Bai Ku
Yao were different among the three genotypes (P <
0.05), the G allele carriers had higher serum HDL-C
levels than the G allele noncarriers. For the Han popu-
lation, the levels of TC, HDL-C and ApoAI among the
three genotypes were different (P < 0.05), the subjects
with GA genotype had lower serum TC, HDL-C and
ApoAI levels than the subjects with AA genotype.
When serum lipid parameters in Han were stratified
according to sex, we showed that the levels of TC,
HDL-C and ApoAI in females but not in males were
different among the AA, GA and GG genotypes (P <
0.05), the participants with GA genotype had lower
serum TC, HDL-C and ApoAI levels than the partici-
pants with AA genotype.
Risk factors for serum lipid parameters
Multiple linear regression analysis showed that serum
TG and HDL-C levels in Bai Ku Yao were correlated
with the genotypes of rs3757354 SNP (P < 0.05 for each;
Table 4), whereas the levels of TC in Han (Table 4), and
TC, LDL-C in Han females (Table 5) were correlated
with the genotypes (P < 0.05 for all).
Serum lipid parameters were also correlated with sev-
eral environmental factors such as age, gender, BMI, al-
cohol consumption, cigarette smoking, blood pressure in
both ethnic groups (P < 0.05-0.001; Table 4).
Discussion
The present study shows that the levels of serum TC,
HDL-C, LDL-C, ApoAI and ApoB were lower in Bai Ku
Yao than in Han. There were no significant differences
Figure 3 A part of the nucleotide sequence of rs3757354 SNP. (A) AA genotype; (B) GA genotype; (C) GG genotype.
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the two ethnic groups. It is well known that dyslipidemia
is the result of a combination of genetic and environ-
mental factors [6-9]. LDL-C, HDL-C and TG concentra-
tions are strongly influenced by the genetic constitution
of each individual. Bai Ku Yao is a special and isolated
subgroup of the Yao minority in China. Strict intra-
ethnic marriages have been performed in this population
from time immemorial. Therefore, we believed that the
genetic background and some lipid metabolism-related
gene polymorphisms in this population may be different
from those in Han nationality.Table 2 The genotypic and allelic frequencies of rs3757354 S
Group n Genotype
AA GA
Bai Ku Yao 627 160 (25.52) 308 (49.12)




Male 303 75 (24.75) 161 (53.14)




Male 294 61 (20.75) 142 (48.30)
Female 320 61 (19.06) 151 (47.19)
χ2 – 0.629
P – 0.730In the present study, we showed that the frequency G
allele of rs3757354 SNP was lower in Bai Ku Yao than in
Han. The frequencies of AA, GA and GG genotypes
were also different between the two ethnic groups. There
were no significant differences in the genotypic and al-
lelic frequencies between males and females in both eth-
nic groups. These results indicated that the prevalence
of the G allele variant of the rs3757354 SNP may have a
racial/ethnic specificity.
The potential relationship between the MYLIP SNPs
and plasma or serum lipid levels in humans has been
evaluated in several previous GWAS. However, previousNP in the Bai Ku Yao and Han populations [n (%)]
Allele
GG G T
159 (25.36) 628 (50.08) 626 (49.92)
199 (32.41) 537 (43.73) 691 (56.27)
10.045
0.002
67 (22.11) 311 (51.32) 295 (48.68)
92 (28.40) 317 (48.92) 331 (51.08)
0.722
0.397
91 (30.95) 264 (44.90) 324 (55.10)
108 (33.75) 273 (42.66) 367 (57.34)
0.626
0.454
Table 3 The genotypes of rs3757354 SNP and serum lipid levels in the Bai Ku Yao and Han populations
Genotype n TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L) ApoAI (g/L) ApoB (g/L) ApoAI/ ApoB
Bai Ku Yao
AA 160 4.38±1.16 1.06(0.66) 1.67±0.47 2.58±0.97 1.31±0.35 0.84±0.24 1.72±0.88
GA 308 4.36±0.87 1.00(0.76) 1.68±0.38 2.55±0.70 1.33±0.30 0.85±0.23 1.70±0.77
GG 159 4.42±0.78 0.96(0.57) 1.76±0.45 2.60±0.71 1.36±0.34 0.84±0.21 1.77±0.79
F – 0.150 2.437 3.206 0.162 2.052 0.354 1.241
P – 0.861 0.296 0.041 0.851 0.129 0.702 0.290
Han Chinese
AA 122 4.97±1.01 1.15(0.74) 1.93±0.49 2.70±0.81 1.47±0.29 0.91±0.21 1.69±0.46
GA 293 4.72±1.05 1.02(0.78) 1.81±0.44 2.66±0.81 1.40±0.25 0.90±0.24 1.65±0.50
GG 199 4.72±0.88 1.02(0.58) 1.92±0.52 2.64±0.68 1.43±0.29 0.88±0.20 1.70±0.58
F 4.635 2.494 3.871 0.644 3.394 1.070 0.347
P 0.010 0.287 0.021 0.526 0.034 0.343 0.707
Bai Ku Yao/male
AA 75 4.44±1.50 1.17(0.82) 1.72±0.55 2.53±1.27 1.37±0.40 0.81±0.28 1.93±1.17
GA 161 4.35±0.94 1.11(0.96) 1.71±0.42 2.47±0.76 1.38±0.34 0.82±0.23 1.86±0.94
GG 67 4.52±0.85 1.11(0.74) 1.81±0.52 2.60±0.83 1.45±0.41 0.83±0.24 1.97±1.05
F – 0.216 0.284 0.979 0.314 1.315 0.051 0.193
P – 0.806 0.867 0.377 0.731 0.270 0.950 0.825
Bai Ku Yao/female
AA 85 4.33±0.76 0.97(0.55) 1.62±0.39 2.62±0.59 1.26±0.29 0.86±0.21 1.53±0.43
GA 147 4.37±0.79 0.93(0.59) 1.66±0.33 2.64±0.62 1.27±0.25 0.88±0.23 1.53±0.48
GG 92 4.34±0.71 0.85(0.47) 1.73±0.39 2.60±0.61 1.30±0.26 0.84±0.19 1.62±0.48
F 0.016 3.755 1.833 0.144 0.734 0.508 1.125
P 0.984 0.153 0.162 0.866 0.481 0.602 0.326
Han/male
AA 61 4.90±0.91 1.27(0.99) 1.84±0.43 2.62±0.72 1.42±0.23 0.90±0.22 1.66±0.43
GA 142 4.74±1.04 1.03(0.79) 1.83±0.47 2.65±0.81 1.41±0.26 0.89±0.23 1.67±0.50
GG 91 4.66±0.90 1.08(0.75) 1.83±0.49 2.66±0.72 1.37±0.29 0.89±0.22 1.63±0.66
F – 1.247 4.060 0.058 0.093 0.925 0.157 0.276
P – 0.289 0.131 0.943 0.912 0.398 0.854 0.759
Han/female
AA 61 5.03±1.10 1.03(0.76) 2.01±0.54 2.78±0.89 1.51±0.33 0.92±0.21 1.71±0.49
GA 151 4.70±1.06 1.00(0.74) 1.80±0.41 2.66±0.80 1.38±0.24 0.91±0.26 1.63±0.50
GG 108 4.76±0.86 0.99(0.49) 2.01±0.53 2.62±0.66 1.48±0.29 0.88±0.18 1.75±0.49
F – 4.063 0.039 6.623 2.290 5.796 1.109 1.342
P – 0.018 0.981 0.002 0.103 0.003 0.331 0.263
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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changes in plasma lipid levels were inconsistent.
MYLIP in GWAS has been shown significant associa-
tions with LDL-C concentrations in Europeans [15-17].
Jeemon et al. [49] identified several novel loci including
rs3757354 SNP associated with LDL-C in the implica-
tions of discoveries from genome-wide association
studies. Teslovich et al. [23], Waterworth et al. [25]
and Weissglas-Volkov et al. [35] also demonstrated thatrs3757354 SNP was genome-wide significant associ-
ation with LDL-C. Furthermore, Banka et al. [37] and
Kararigas et al. [38] found that MYLIP is a sex-specific
element influencing contractile function. However, San-
tos et al. [36] showed MYLIP p.N342S polymorphism
was not associated with lipid profiles in the Brazilian
population. In the present study, we showed that the
levels of HDL-C in Bai Ku Yao were different among
the three genotypes, the G allele carriers had higher
Table 4 Correlation between the genotypes of rs3757354 SNP and serum lipid parameters in the Bai Ku Yao and Han
populations






TC Body mass index 0.066 0.010 0.191 6.918 0.000
Ethnic group 0.367 0.053 0.187 6.985 0.000
Age 0.007 0.002 0.107 3.932 0.000
Diastolic blood pressure 0.010 0.003 0.104 3.706 0.000
TG Body mass index 0.064 0.011 0.163 5.699 0.000
Gender −0.244 0.067 −0.110 −3.660 0.000
Genotype −0.112 0.043 −0.072 −2.612 0.009
Diastolic blood pressure 0.007 0.003 0.063 2.192 0.028
Alcohol consumption 0.095 0.046 0.063 2.079 0.037
HDL-C Ethnic group 0.184 0.025 0.200 7.276 0.000
Alcohol consumption 0.122 0.019 0.196 6.295 0.000
Age 0.004 0.001 0.131 4.811 0.000
Body mass index −0.017 0.004 −0.103 −3.766 0.000
Cigarette smoking −0.064 0.019 −0.105 −3.392 0.000
Genotype 0.038 0.017 0.060 2.192 0.028
LDL-C Body mass index 0.061 0.008 0.224 7.972 0.000
Age 0.006 0.001 0.112 4.058 0.000
Alcohol consumption −0.130 0.029 −0.124 −4.465 0.000
Diastolic blood pressure 0.006 0.002 0.082 2.834 0.004
ApoAI Alcohol consumption 0.087 0.011 0.213 7.795 0.000
Ethnic group 0.104 0.016 0.172 6.333 0.000
Age 0.003 0.001 0.168 6.195 0.000
ApoB Body mass index 0.019 0.002 0.233 8.445 0.000
Age 0.002 0.000 0.124 4.547 0.000
Diastolic blood pressure 0.003 0.001 0.126 4.432 0.000
Ethnic group 0.045 0.012 0.098 3.620 0.000
Alcohol consumption −0.020 0.009 −0.065 −2.360 0.018
ApoAI/ApoB Alcohol consumption 0.186 0.026 0.202 7.210 0.000
Body mass index −0.036 0.007 −0.153 −5.376 0.000
Diastolic blood pressure −0.004 0.002 −0.068 −2.382 0.017
Bai Ku Yao
TC Body mass index 0.085 0.015 0.218 5.597 0.000
Age 0.009 0.003 0.132 3.392 0.000
TG Alcohol consumption 0.217 0.075 0.142 2.888 0.004
Body mass index 0.076 0.019 0.157 4.055 0.000
Gender −0.507 0.129 −0.219 −3.922 0.000
Cigarette smoking −0.201 0.079 −0.138 −2.552 0.010
Genotype −0.132 0.062 −0.081 −2.118 0.034
HDL-C Alcohol consumption 0.092 0.022 0.165 4.200 0.000
Age 0.003 0.001 0.111 2.837 0.004
Genotype 0.051 0.023 0.087 2.212 0.027
LDL-C Body mass index 0.071 0.013 0.219 5.616 0.000
Age 0.007 0.002 0.120 3.023 0.002
Alcohol consumption −0.144 0.041 −0.140 −3.548 0.000
Diastolic blood pressure 0.007 0.003 0.092 2.268 0.023
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Table 4 Correlation between the genotypes of rs3757354 SNP and serum lipid parameters in the Bai Ku Yao and Han
populations (Continued)
ApoAI Alcohol consumption 0.119 0.016 0.279 7.289 0.000
Age 0.002 0.001 0.101 2.649 0.008
ApoB Body mass index 0.023 0.004 0.242 6.249 0.000
Age 0.002 0.001 0.138 3.501 0.000
Alcohol consumption −0.041 0.012 −0.136 −3.491 0.000
Diastolic blood pressure 0.003 0.001 0.108 2.685 0.007
ApoAI/ApoB Alcohol consumption 0.288 0.041 0.271 7.071 0.000
Body mass index −0.053 0.013 −0.158 −4.133 0.000
Han
TC Body mass index 0.062 0.012 0.202 5.021 0.000
Systolic blood pressure 0.007 0.002 0.122 2.969 0.003
Age 0.006 0.003 0.101 2.550 0.011
Genotype −0.118 0.054 −0.085 −2.186 0.029
TG Body mass index 0.053 0.014 0.162 3.913 0.000
Diastolic blood pressure 0.010 0.004 0.105 2.525 0.011
Cigarette smoking 0.153 0.060 0.100 2.522 0.011
HDL-C Age 0.005 0.001 0.160 4.088 0.000
Alcohol consumption 0.133 0.029 0.196 4.655 0.000
Cigarette smoking −0.103 0.029 −0.151 −3.546 0.000
Body mass index −0.018 0.006 −0.125 −3.194 0.001
Gender 0.084 0.039 0.087 2.166 0.030
LDL-C Body mass index 0.062 0.009 0.263 6.773 0.000
Age 0.006 0.002 0.117 3.015 0.002
Alcohol consumption −0.148 0.045 −0.136 −3.264 0.001
Cigarette smoking 0.140 0.045 0.127 3.073 0.002
ApoAI Age 0.004 0.001 0.252 6.524 0.000
Alcohol consumption 0.057 0.015 0.148 3.774 0.000
Gender 0.059 0.021 0.108 2.763 0.005
ApoB Body mass index 0.017 0.003 0.240 6.115 0.000
Systolic blood pressure 0.002 0.001 0.153 3.802 0.000
Age 0.002 0.001 0.106 2.705 0.007
ApoAI/ApoB Body mass index −0.031 0.006 −0.191 −4.823 0.000
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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levels of TC, HDL-C and ApoAI in Han were also dif-
ferent among the three genotypes, the subjects with
GA genotype had lower serum TC, HDL-C and ApoAI
levels than the subjects with AA genotype. These find-
ings were restricted to females but not males. Multiple
linear regression analysis also showed that serum TG
and HDL-C levels in Bai Ku Yao were correlated with
the genotypes of rs3757354 SNP, whereas the levels of
TC in Han, and TC, LDL-C in Han females were asso-
ciated with the genotypes. These findings suggest that
the association of MYLIP rs3757354 SNP and serum
lipid levels is different between the two ethnic groups.There may be a sex-specific association of rs3757354
SNP and serum lipid parameters in Han population.
It is well known that environmental factors such as
dietary patterns, lifestyle, obesity, physical inactivity, and
hypertension are all strongly related with serum lipid
levels [6,7]. Furthermore, exposure to different lifestyle
and environmental factors in our population resident in
Guangxi may further modify the effect of genetic vari-
ation on serum lipid phenotypes. Multivariate linear re-
gression analysis showed that age, sex, BMI, alcohol
consumption, cigarette smoking, and blood pressure
were involved in determining serum lipid parameters.
These findings suggest that the environmental factors
Table 5 Relative factors for serum lipid parameters between males and females in both ethnic groups






TC Body mass index 0.136 0.027 0.277 5.004 0.000
TG Body mass index 0.137 0.038 0.204 3.611 0.000
HDL-C Alcohol consumption 0.132 0.036 0.207 3.681 0.000
Age 0.005 0.002 0.159 2.836 0.004
Body mass index −0.028 0.012 −0.131 −2.364 0.018
LDL-C Body mass index 0.113 0.023 0.271 4.877 0.000
ApoAI Alcohol consumption 0.134 0.028 0.271 4.883 0.000
Age 0.003 0.001 0.126 2.273 0.023
ApoB Body mass index 0.031 0.006 0.279 5.024 0.000
Diastolic blood pressure 0.003 0.001 0.113 2.028 0.043
ApoAI/ApoB Alcohol consumption 0.290 0.077 0.212 3.790 0.000
Body mass index −0.090 0.026 −0.196 −3.513 0.000
Bai Ku Yao/female
TC Age 0.011 0.003 0.192 3.511 0.000
Body mass index 0.059 0.017 0.196 3.528 0.000
Alcohol consumption −0.205 0.090 −0.126 −2.275 0.023
TG Alcohol consumption 0.207 0.075 0.151 2.742 0.006
Body mass index 0.039 0.014 0.156 2.833 0.004
Genotype −0.108 0.046 −0.126 −2.337 0.020
LDL-C Age 0.009 0.002 0.212 3.917 0.000
Body mass index 0.050 0.013 0.211 3.823 0.000
Alcohol consumption −0.222 0.072 −0.169 −3.092 0.002
ApoB Diastolic blood pressure 0.003 0.001 0.113 2.019 0.044
Body mass index 0.015 0.005 0.179 3.259 0.001
Age 0.003 0.001 0.166 2.957 0.003
ApoAI/ApoB Diastolic blood pressure −0.009 0.003 −0.185 −3.373 0.000
Alcohol consumption 0.113 0.055 0.112 2.052 0.040
Han/male
TC Diastolic blood pressure 0.012 0.005 0.148 2.471 0.014
Body mass index 0.037 0.017 0.128 2.139 0.033
Age 0.007 0.004 0.122 2.137 0.033
TG Diastolic blood pressure 0.019 0.006 0.179 2.999 0.002
Body mass index 0.054 0.022 0.150 2.510 0.012
HDL-C Alcohol consumption 0.186 0.036 0.300 5.166 0.000
Age 0.004 0.002 0.145 2.610 0.009
Cigarette smoking −0.089 0.033 −0.157 −2.736 0.006
Body mass index −0.018 0.008 −0.131 −2.366 0.018
LDL-C Body mass index 0.050 0.013 0.220 3.875 0.000
Cigarette smoking 0.177 0.055 0.189 3.212 0.001
Alcohol consumption −0.139 0.060 −0.136 −2.300 0.022
ApoAI Age 0.004 0.001 0.265 4.850 0.000
Alcohol consumption 0.087 0.019 0.246 4.495 0.000
ApoB Body mass index 0.014 0.004 0.215 3.822 0.000
Age 0.002 0.001 0.168 2.976 0.003
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Table 5 Relative factors for serum lipid parameters between males and females in both ethnic groups (Continued)
ApoAI/ApoB Alcohol consumption 0.151 0.041 0.209 3.668 0.000
Body mass index −0.026 0.009 −0.162 −2.851 0.004
Han/female
TC Body mass index 0.086 0.018 0.268 4.829 0.000
Systolic blood pressure 0.008 0.003 0.144 2.618 0.009
Genotype −0.153 0.076 −0.108 −2.020 0.044
TG Cigarette smoking 0.335 0.095 0.192 3.538 0.000
Body mass index 0.048 0.015 0.171 3.160 0.001
HDL-C Age 0.005 0.002 0.169 3.028 0.002
Body mass index −0.017 0.009 −0.111 −1.992 0.047
LDL-C Body mass index 0.078 0.013 0.318 5.922 0.000
Genotype −0.124 0.058 −0.114 −2.145 0.032
Age 0.006 0.003 0.109 2.060 0.040
ApoAI Age 0.004 0.001 0.234 4.284 0.000
ApoB Body mass index 0.020 0.004 0.279 5.308 0.000
Systolic blood pressure 0.003 0.001 0.225 4.285 0.000
Alcohol consumption 0.045 0.018 0.128 2.503 0.012
ApoAI/ApoB Body mass index −0.037 0.009 −0.234 −4.325 0.000
Cigarette smoking −0.119 0.053 −0.122 −2.254 0.024
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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levels in our study populations. Differences in serum
lipid levels between the two ethnic groups could be
related to factors such as differences in the genetic back-
ground, dietary patterns and lifestyle factors and their
interactions. Although Bai Ku Yao and Han reside in the
same region, there were significant differences in their
diet and lifestyle. Corn was the staple food and rice, soy,
buck wheat, sweet potato, and pumpkin products were
the subsidiary foods in Bai Ku Yao. Approximately 90%
of the beverages were corn wine and rum. The alcohol
content is about 15% (v/v). They are also accustomed to
drink Hempseed soup. In contrast, rice was the staple
food and corn, broomcorn, potato, and taro products
were the subsidiary foods in Han. About 90% of the bev-
erage was rice wine. The content of alcohol is about 30%
(v /v). The staple and subsidiary foods are more favor-
able for serum lipid profiles in Bai Ku Yao than in Han.
Corn contains abundant dietary fiber and plant protein
[50]. Dietary fiber can decrease serum TC levels [51].
Plant protein can promote the transportation and excre-
tion of free cholesterol. Dietary soy protein has well
documented beneficial effects on serum lipid concentra-
tions [52,53].
Conclusion
The present study shows that there were significant dif-
ferences in the genotypic and allelic frequencies of
MYLIP rs3757354 SNP between Bai Ku Yao and Hanpopulations. The levels of HDL-C in Bai Ku Yao were
different among the genotypes, the G allele carriers had
higher serum HDL-C levels than the G allele noncar-
riers. The levels TC, HDL-C and ApoAI in Han were
different among the genotypes, the participants with GA
genotype had lower serum TC, HDL-C and ApoAI levels
than the participants with AA genotype. The levels of
TG and HDL-C in Bai Ku Yao were correlated with the
genotypes, whereas the levels of TC in Han, and TC,
LDL-C in Han females were associated with the geno-
types. These results suggest that the association of
MYLIP rs3757354 SNP and serum lipid levels is different
between the two ethnic groups. There may be a sex-
specific association of rs3757354 SNP and serum lipid
parameters in the Han population.
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